- Home
- RLTY vs QTRX Comparison
RLTY vs QTRX Comparison
Compare RLTY & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLTY
- QTRX
- Stock Information
- Founded
- RLTY 2022
- QTRX 2007
- Country
- RLTY United States
- QTRX United States
- Employees
- RLTY N/A
- QTRX N/A
- Industry
- RLTY Investment Managers
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- RLTY Finance
- QTRX Industrials
- Exchange
- RLTY Nasdaq
- QTRX Nasdaq
- Market Cap
- RLTY 253.7M
- QTRX 241.2M
- IPO Year
- RLTY N/A
- QTRX 2017
- Fundamental
- Price
- RLTY $15.24
- QTRX $5.77
- Analyst Decision
- RLTY
- QTRX Hold
- Analyst Count
- RLTY 0
- QTRX 4
- Target Price
- RLTY N/A
- QTRX $11.75
- AVG Volume (30 Days)
- RLTY 86.7K
- QTRX 433.1K
- Earning Date
- RLTY 01-01-0001
- QTRX 11-11-2025
- Dividend Yield
- RLTY 9.35%
- QTRX N/A
- EPS Growth
- RLTY N/A
- QTRX N/A
- EPS
- RLTY N/A
- QTRX N/A
- Revenue
- RLTY N/A
- QTRX $125,784,000.00
- Revenue This Year
- RLTY N/A
- QTRX N/A
- Revenue Next Year
- RLTY N/A
- QTRX $37.89
- P/E Ratio
- RLTY N/A
- QTRX N/A
- Revenue Growth
- RLTY N/A
- QTRX N/A
- 52 Week Low
- RLTY $11.38
- QTRX $4.05
- 52 Week High
- RLTY $14.60
- QTRX $15.67
- Technical
- Relative Strength Index (RSI)
- RLTY 49.05
- QTRX 53.23
- Support Level
- RLTY $15.15
- QTRX $5.60
- Resistance Level
- RLTY $15.40
- QTRX $6.25
- Average True Range (ATR)
- RLTY 0.19
- QTRX 0.35
- MACD
- RLTY 0.03
- QTRX -0.02
- Stochastic Oscillator
- RLTY 63.03
- QTRX 25.71
About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.